Global X Genomics & Biotechnology ETF (GNOM) Holdings $8.85 -0.17 (-1.88%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$8.93 +0.08 (+0.95%) As of 07/11/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 50 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1ALNYAlnylam Pharmaceuticals$314.94-2.4%5.16%7,2212CRSPCRISPR Therapeutics$56.80-3.7%5.07%45,3343ILMNIllumina$99.25-0.8%4.98%22,9144QGENQiagen$48.13-0.9%4.35%41,2855MRNAModerna$33.64-1.9%4.32%65,8326GHGuardant Health$50.25-2.0%4.16%38,2827NTRANatera$160.43-1.8%4.12%11,7618TECHBio-Techne$54.14-0.5%4.01%34,8329RAREUltragenyx Pharmaceutical$29.51-4.9%4.00%46,82910LEGNLegend Biotech$38.96-1.9%3.96%50,939 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11RNAAvidity Biosciences$31.45-0.1%3.62%56,94912BNTXBioNTech$112.89-0.9%3.57%15,21513VRTXVertex Pharmaceuticals$468.85-2.2%3.51%3,54814BMRNBioMarin Pharmaceutical$58.10-1.2%3.49%28,20815WGSGeneDx$82.56-5.0%2.76%14,20916Genscript Biotech CorporationN/A2.67%636,11817TWSTTwist Bioscience$38.03-1.1%2.63%32,21218VCYTVeracyte$27.08-1.6%2.63%43,99419ARWRArrowhead Pharmaceuticals$18.31-2.9%2.39%65,21020AAgilent Technologies$123.35-0.7%2.17%8,29521BEAMBeam Therapeutics$21.16-3.9%2.11%49,06422GILDGilead Sciences$109.64-4.3%1.98%8,18023AstraZeneca PLCN/A1.94%6,33824BMYBristol Myers Squibb$46.91-3.3%1.85%17,96425LLYEli Lilly and Company$793.34+0.3%1.77%1,05126TXG10x Genomics$12.80+1.4%1.64%58,15827NTLAIntellia Therapeutics$11.53-5.2%1.29%55,60128CDNACareDx$20.13-2.4%1.25%29,49229SRPTSarepta Therapeutics$18.17-4.7%1.16%29,36930PRAXPraxis Precision Medicines$50.54+0.5%1.08%10,76231WVEWAVE Life Sciences$7.70-3.1%1.02%69,93932VERVVerve Therapeutics$11.03-0.3%0.92%37,80033QUREuniQure$14.40-3.2%0.87%28,22534CVACCureVac$5.46+0.2%0.63%53,50335MYGNMyriad Genetics$5.34-2.9%0.61%50,17936STOKStoke Therapeutics$11.86-1.5%0.59%23,72637VIRVir Biotechnology$5.65-4.7%0.59%50,15738PSNLPersonalis$6.37-7.9%0.58%35,41939FLGTFulgent Genetics$19.27-1.4%0.49%11,30840PACBPacific Biosciences of California$1.47-2.0%0.48%150,268The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again.41PRMEPrime Medicine$4.35-7.2%0.48%72,89742RGNXREGENXBIO$8.68-4.2%0.48%25,73543SANASana Biotechnology$4.18+3.0%0.48%76,07344ARCTArcturus Therapeutics$13.78-4.8%0.41%13,87345MRVIMaravai LifeSciences$2.73-5.5%0.38%66,50046RCKTRocket Pharmaceuticals$2.96-6.3%0.35%56,47647CashN/A0.29%136,00348CRGXCARGO Therapeutics$4.59-0.2%0.27%28,54549ALLOAllogene Therapeutics$1.28+1.6%0.21%80,62950SGMOSangamo Therapeutics$0.49-1.6%0.20%172,412 Geographic ExposureUnited States82.4%Switzerland5.5%Netherlands4.3%Cayman Islands2.6%United Kingdom1.9%Singapore1.2%Currency ExposureUSD75.9%HKD2.6%GBP1.9%Sector ExposureHealth Care90.2%Materials4.3%Consumer Discretionary4.1%Energy0.5%Industry ExposureBiotechnology61.0%Health Care Equipment & Supplies16.0%Health Care Providers & Services7.0%Life Sciences Tools & Services5.1%Metals & Mining4.3%Diversified Consumer Services4.1%Pharmaceuticals1.2%Renewable Energy0.5%SubIndustry ExposureBiotechnology60.7%Life Sciences Tools & Services19.7%Health Care Services7.0%Diversified Metals & Mining4.3%Health Care Equipment1.3%Pharmaceuticals1.2%Renewable Energy Equipment0.5% Related Companies and Tools Related Companies DEMZ Holdings TEKY Holdings SARK Holdings CEPI Holdings FDNI Holdings BLCN Holdings SETM Holdings TARK Holdings FMET Holdings ELFY Holdings This page (NASDAQ:GNOM) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.